ATC Group: S01GA07 Brimonidine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of S01GA07 in the ATC hierarchy

Level Code Title
1 S Sensory organs
2 S01 Ophthalmologicals
3 S01G Decongestants and antiallergics
4 S01GA Sympathomimetics used as decongestants
5 S01GA07

Active ingredients in S01GA07

Active Ingredient Description
Brimonidine

Brimonidine is an alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenoceptor than the alpha1-adrenoreceptor. This selectivity results in no mydriasis and the absence of vasoconstriction in microvessels associated with human retinal xenografts.

Medicines in this ATC group

United States (US)

Canada (CA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.